Daniel Virnich serves as Executive at Oncology Institute, Inc., where they oversee executive responsibilities. Since joining the company, Daniel Virnich has executed 15 insider transactions totaling $7.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 17, 2025 involved receiving (via award) 6,464 shares valued at $0.
Daniel Virnich currently holds 1,799,984 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Virnich has been a net seller of TOI stock. They have purchased $0 and sold $7.6K worth of shares.
Daniel Virnich's most recent insider trade was on Nov 17, 2025, when they sold 6,464 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 21, 2024 | TOI | $0 | Award | 198,517 | $N/A | Discretionary |
| May 21, 2024 | TOI | $6.7K | Disposition | 11,173 | $0.60 | Discretionary |
| Nov 21, 2023 | TOI | $9.5K | Disposition | 4,322 | $2.19 | Discretionary |
| Nov 14, 2023 | TOI | $11.0K | Disposition | 4,604 | $2.39 | Discretionary |
| Mar 17, 2023 | TOI | $0 | Award | 114,944 | $N/A | Discretionary |
| Dec 7, 2022 | TOI | $150.5K | Option Exercise | 175,000 | $0.86 | Discretionary |
| Dec 7, 2022 | TOI | $150.5K | Option Exercise | 175,000 | $0.86 | Discretionary |
| Nov 17, 2022 | TOI | $0 | Award | 40,101 | $N/A | Discretionary |
| Nov 15, 2022 | TOI | $7.6K | Disposition | 3,767 | $2.03 | Discretionary |
| Nov 15, 2022 | TOI | $7.6K | Sale | 3,767 | $2.03 | Discretionary |
| Mar 21, 2022 | TOI | $0 | Award | 42,015 | $N/A | Discretionary |
| Nov 12, 2021 | TOI | $0 | Award | 117,142 | $N/A | Discretionary |
| Nov 12, 2021 | TOI | $0 | Award | 78,094 | $N/A | Discretionary |